Correlation Between Quince Therapeutics, and Blue Line
Can any of the company-specific risk be diversified away by investing in both Quince Therapeutics, and Blue Line at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quince Therapeutics, and Blue Line into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quince Therapeutics, and Blue Line Protection, you can compare the effects of market volatilities on Quince Therapeutics, and Blue Line and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quince Therapeutics, with a short position of Blue Line. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quince Therapeutics, and Blue Line.
Diversification Opportunities for Quince Therapeutics, and Blue Line
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Quince and Blue is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Quince Therapeutics, and Blue Line Protection in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blue Line Protection and Quince Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quince Therapeutics, are associated (or correlated) with Blue Line. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blue Line Protection has no effect on the direction of Quince Therapeutics, i.e., Quince Therapeutics, and Blue Line go up and down completely randomly.
Pair Corralation between Quince Therapeutics, and Blue Line
Given the investment horizon of 90 days Quince Therapeutics, is expected to under-perform the Blue Line. But the stock apears to be less risky and, when comparing its historical volatility, Quince Therapeutics, is 1.94 times less risky than Blue Line. The stock trades about -0.14 of its potential returns per unit of risk. The Blue Line Protection is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 6.19 in Blue Line Protection on November 2, 2024 and sell it today you would lose (0.19) from holding Blue Line Protection or give up 3.07% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 90.48% |
Values | Daily Returns |
Quince Therapeutics, vs. Blue Line Protection
Performance |
Timeline |
Quince Therapeutics, |
Blue Line Protection |
Quince Therapeutics, and Blue Line Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Quince Therapeutics, and Blue Line
The main advantage of trading using opposite Quince Therapeutics, and Blue Line positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quince Therapeutics, position performs unexpectedly, Blue Line can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blue Line will offset losses from the drop in Blue Line's long position.Quince Therapeutics, vs. Nuvation Bio | Quince Therapeutics, vs. Assembly Biosciences | Quince Therapeutics, vs. Instil Bio | Quince Therapeutics, vs. Achilles Therapeutics PLC |
Blue Line vs. BIO Key International | Blue Line vs. LogicMark | Blue Line vs. Knightscope | Blue Line vs. Guardforce AI Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |